Company logo

CPRX - Catalyst Pharmaceuticals, Inc.

NASDAQ -> Healthcare -> Biotechnology
Coral Gables, United States
Type: Equity

CPRX price evolution
CPRX
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Current assets
Cash $137.64 $120.97 $178.79 $148.25
Short term investments
Net receivables $53.51 $48.05 $42.8 $33.4
Inventory $15.64 $9.04 $10.75 $10.33
Total current assets $219.33 $192.02 $240.97 $198.91
Long term investments $16.49 $12.9
Property, plant & equipment $3.7 $3.76 $3.84 $3.99
Goodwill & intangible assets $194.05 $167.11 $175.59 $184.08
Total noncurrent assets $250.78 $221.19 $202.93 $208.32
Total investments $16.49 $12.9
Total assets $470.11 $413.21 $443.9 $407.23
Current liabilities
Accounts payable $14.79 $4.6 $4.42 $3.39
Deferred revenue
Short long term debt
Total current liabilities $76.06 $57.81 $52.5 $56.71
Long term debt $3.19 $3.28 $3.38 $3.47
Total noncurrent liabilities $6.17 $6.86 $16.1 $16.86
Total debt $3.19 $3.28 $3.38 $3.47
Total liabilities $82.23 $64.66 $68.6 $73.57
Shareholders' equity
Retained earnings $121.27 $86.43 $117.19 $79.43
Other shareholder equity $0.01 $0.01 $0.02 $0.01
Total shareholder equity $387.88 $348.55 $375.29 $333.66
(in millions $) 31 Dec 2023 31 Jan 2023 31 Dec 2021 31 Dec 2020
Current assets
Cash $137.64 $298.4 $171.45 $130.25
Short term investments $19.82 $10.04
Net receivables $53.51 $10.44 $6.62 $5.99
Inventory $15.64 $6.8 $7.87 $4.65
Total current assets $219.33 $320.8 $210.11 $159.24
Long term investments $16.49
Property, plant & equipment $3.7 $3.62 $3.98 $0.13
Goodwill & intangible assets $194.05 $32.47
Total noncurrent assets $250.78 $54.83 $27.68 $33.11
Total investments $16.49 $19.82 $10.04
Total assets $470.11 $375.63 $237.79 $192.35
Current liabilities
Accounts payable $14.79 $3.98 $2.77 $4.26
Deferred revenue
Short long term debt
Total current liabilities $76.06 $57.59 $27.06 $22.76
Long term debt $3.19 $3.56 $3.89
Total noncurrent liabilities $6.17 $17.62 $3.89
Total debt $3.19 $3.56 $3.89
Total liabilities $82.23 $75.21 $30.96 $22.76
Shareholders' equity
Retained earnings $121.27 $49.86 -$26.31 -$53.71
Other shareholder equity $0.01 $0.02 -$0.15 $0.03
Total shareholder equity $387.88 $300.42 $206.83 $169.6
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Revenue
Total revenue $110.57 $102.69 $99.58 $85.37
Cost of revenue $15.81 $14.17 $12.04 $9.95
Gross Profit $94.76 $88.52 $87.54 $75.42
Operating activities
Research & development $1.97 $83.66 $3.95 $3.56
Selling, general & administrative $42.04 $33.56 $28.4 $29.72
Total operating expenses $53.07 $125.71 $40.84 $39.81
Operating income $41.69 -$37.19 $46.7 $35.61
Income from continuing operations
EBIT $46.71 -$38.02 $48.51 $37.31
Income tax expense $11.86 -$7.26 $10.75 $7.75
Interest expense
Net income
Net income $34.84 -$30.76 $37.76 $29.57
Income (for common shares) $34.84 -$30.76 $37.76 $29.57
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Revenue
Total revenue $398.2 $214.2 $140.83 $119.07
Cost of revenue $51.97 $34.39 $21.88 $17.04
Gross Profit $346.24 $179.81 $118.95 $102.03
Operating activities
Research & development $93.15 $19.79 $16.94 $16.5
Selling, general & administrative $133.71 $58.18 $49.63 $44.23
Total operating expenses $259.43 $77.97 $66.56 $60.73
Operating income $86.81 $101.84 $52.38 $41.3
Income from continuing operations
EBIT $94.51 $104.72 $52.67 $41.89
Income tax expense $23.1 $21.64 $13.19 -$33.09
Interest expense
Net income
Net income $71.41 $83.08 $39.48 $74.98
Income (for common shares) $71.41 $83.08 $39.48 $74.98
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Net income $34.84 -$30.76 $37.76 $29.57
Operating activities
Depreciation $9.21 $8.63 $8.63 $6.66
Business acquisitions & disposals -$36 -$162.29
Stock-based compensation $4.25 $3.81 $3.3 $2.89
Total cash flows from operations $55.65 $45.13 $30.75 $12.07
Investing activities
Capital expenditures -$0.09 -$0.06 -$0.07
Investments -$13.46
Total cash flows from investing -$38.32 -$92.82 -$162.37
Financing activities
Dividends paid
Sale and purchase of stock $0.69 $0.21 $0.62 $1.27
Net borrowings
Total cash flows from financing -$0.67 -$10.13 -$0.21 $0.15
Effect of exchange rate
Change in cash and equivalents $16.66 -$57.82 $30.54 -$150.15
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Net income $71.41 $83.08 $39.48 $74.98
Operating activities
Depreciation $33.14 $1.49 $0.48 $0.89
Business acquisitions & disposals -$198.29 -$10
Stock-based compensation $14.25 $7.91 $6.07 $6.26
Total cash flows from operations $143.6 $116.05 $60.37 $45.03
Investing activities
Capital expenditures -$0.23 -$0.03 -$1.02 -$0.01
Investments -$13.46 $19.24 -$10 -$5
Total cash flows from investing -$293.5 $9.21 -$11.02 -$5.01
Financing activities
Dividends paid
Sale and purchase of stock $2.79 $2.66 -$7.99 $0.76
Net borrowings
Total cash flows from financing -$10.86 $1.69 -$8.14 $0.7
Effect of exchange rate
Change in cash and equivalents -$160.76 $126.95 $41.21 $40.73
Fundamentals
Market cap $1.74B
Enterprise value $1.61B
Shares outstanding 107.12M
Revenue $398.20M
EBITDA $127.65M
EBIT $94.51M
Net Income $71.41M
Revenue Q/Q 81.98%
Revenue Y/Y 85.90%
P/E ratio 24.41
EV/Sales 4.04
EV/EBITDA 12.60
EV/EBIT 17.02
P/S ratio 4.38
P/B ratio 4.49
Book/Share 3.62
Cash/Share 1.28
EPS $0.67
ROA 16.47%
ROE 19.76%
Debt/Equity 0.21
Net debt/EBITDA -0.43
Current ratio 2.88
Quick ratio 2.68